Arabinose-5-phosphate isomerases (APIs) catalyze the interconversion of D-ribulose-5-phosphate and D-arabinose-5-phosphate, the first step in the biosynthesis of 3-deoxy-D-manno-octulosonic acid (Kdo), an essential component of the lipopolysaccharide in Gram-negative bacteria. Classical APIs, such as Escherichia coli KdsD, contain a sugar isomerase domain and a tandem cystathionine beta-synthase domain. Despite substantial effort, little is known about structure-function relationships in these APIs. We recently reported an API containing only a sugar isomerase domain. This protein, c3406 from E. coli CFT073, has no known physiological function. In this study, we investigated a putative single-domain API from the anaerobic Gram-negative bacterium Bacteroides fragilis. This putative API (UniProt ID Q5LIW1) is the only protein encoded by the B. fragilis genome with significant identity to any known API, suggesting that it is responsible for lipopolysaccharide biosynthesis in B. fragilis. We tested this hypothesis by preparing recombinant Q5LIW1 protein (here referred to by the UniProt ID Q5LIW1), characterizing its API activity in vitro, and demonstrating that the gene encoding Q5LIW1 (GenBank ID YP_209877.1) was able to complement an APIdeficient E. coli strain. We demonstrated that Q5LIW1 is inhibited by cytidine 5=-monophospho-3-deoxy-D-manno-2-octulosonic acid, the final product of the Kdo biosynthesis pathway, with a K i of 1.91 M. These results support the assertion that Q5LIW1 is the API that supports lipopolysaccharide biosynthesis in B. fragilis and is subject to feedback regulation by CMPKdo. The sugar isomerase domain of E. coli KdsD, lacking the two cystathionine beta-synthase domains, demonstrated API activity and was further characterized. These results suggest that Q5LIW1 may be a suitable system to study API structure-function relationships.
A rabinose-5-phosphate isomerases (APIs) catalyze the interconversion of D-ribulose-5-phosphate (Ru5P), the product of the oxidative phase of the pentose phosphate pathway (1) , and D-arabinose-5-phosphate (A5P), the first intermediate in the biosynthesis of 3-deoxy-D-manno-octulosonic acid (Kdo). Kdo is an essential component of the cell envelope of Gram-negative bacteria (2) and is also found in certain algae and plants (3) . Kdo biosynthesis and activation represent an attractive pathway for drug targeting because Kdo is not synthesized by humans (4) .
The Woodard laboratory has identified four distinct API genes from various strains of the model Gram-negative organism Escherichia coli. The genome of E. coli K-12 encodes two distinct APIs, KdsD and GutQ. The kdsD gene, formerly known as yrbH, is located in the yrb gene cluster. Its product, KdsD, catalyzes the formation of A5P used in the biosynthesis of Kdo (5) . The gutQ gene is found in the glucitol (sorbitol) operon, which encodes proteins involved in the utilization of glucitol as a sole carbon source. The physiological role of GutQ, which has KdsD-like levels of API activity and can produce sufficient A5P to support Kdo biosynthesis in the absence of KdsD (6) , is somewhat of an enigma because A5P has not been directly implicated in the import or utilization of sorbitol. E. coli strains that produce group II K-antigens (e.g., E. coli CFT073) contain a third API, KpsF. Since group II K-antigens contain Kdo, KpsF is considered responsible for the biosynthesis of the Kdo required by the group II K-antigen biosynthetic machinery (7) . In support of this hypothesis, the kpsF gene is found in the kps cluster, which also contains a homolog of the kdsB gene (kpsU). The kdsB gene encodes cytidine 5=-monophospho-3-deoxy-D-manno-2-octulosonic acid (CMP-Kdo) synthetase, another enzyme in the Kdo biosynthetic pathway. Finally, E. coli CFT073 has a fourth API encoded by the gene given sequence tag c3406. This gene, though found on a genomic island implicated in virulence, is nonessential for the virulent phenotype (8) . Like gutQ, c3406 is situated near a gene implicated in carbohydrate utilization.
Three of these APIs, KdsD, GutQ, and KpsF, consist of two domains-a sugar isomerase (SIS) domain and a tandem cystathionine beta-synthase (CBS) domain. The purpose of the CBS domains in these proteins has not been established, but in other contexts, CBS domains have been implicated in the modulation of enzyme activity (9) . It is also not clear if and how single-domain APIs are regulated. The X-ray crystal structure of a full-length, CBS domain-containing API has remained elusive despite many attempts, including the crystallization of mutants (10) . The lack of a full-length API crystal structure along with very little knowledge about how APIs are regulated has impeded structure-function studies with this enzyme.
The API encoded by c3406, in contrast, consists of a single SIS domain and is therefore much smaller than KdsD, GutQ, and KpsF. A search for similar proteins in the RCSB Protein Data Bank revealed the structure (PDB ID 3ETN) of an SIS domain proteinencoding gene, the YP_209877.1 gene (UniProt ID Q5LIW1) from Bacteroides fragilis NCTC 9343, in complex with CMP-Kdo, the end product of the Kdo biosynthesis pathway. B. fragilis is a Gram-negative anaerobic bacterium that incorporates a Kdocontaining lipopolysaccharide (LPS) in its cell envelope (11) . A search of the B. fragilis NCTC 9343 genome found that it contains an open reading frame orthologous to the genes for all 4 enzymes in the well-established Kdo biosynthetic pathway of E. coli K-12 (kdsD, kdsA, kdsC, and kdsB). The Q5LIW1 protein (referred to here by the UniProt ID Q5LIW1), which shares 34% identity with c3406, is the only protein found in B. fragilis with substantial identity to any API. This information led us to hypothesize that Q5LIW1, like KdsD in E. coli, is the API that supports LPS biosynthesis in B. fragilis and, furthermore, that its enzymatic activity may be feedback regulated by CMP-Kdo. To test these hypotheses, Q5LIW1 was cloned, expressed, and purified. Its activity as an API was subsequently characterized both in vitro and in vivo (E. coli TCM15 cells). Finally, the ability of CMP-Kdo to inhibit the API activity of Q5LIW1 was probed.
Previous reports from our lab have shown that c3406, which is the only API from E. coli that naturally lacks CBS domains, can complement an API defect in E. coli TCM15 (8) . This information, along with the results of the studies of Q5LIW1 reported here, led us to question if a truncated E. coli KdsD containing only the SIS domain would retain sufficient API activity to complement the API deficiency in TCM15. The results of these experiments are also reported below.
MATERIALS AND METHODS

Materials.
Genomic DNA from Bacteroides fragilis NCTC 9343 was purchased from the American Type Culture Collection (catalogue no. 25285D-5). Primers for PCR were synthesized by Integrated DNA Technologies (IDT; Coralville, IA, USA). The Failsafe PCR PreMix selection kit was purchased from Epicentre Biotechnologies (Madison, WI, USA). PCR was performed in an MJ Research PTC-200 Peltier thermal cycler. TA TOPO cloning was performed via the TA TOPO cloning kit purchased from Invitrogen (Grand Island, NY, USA). Enzymes for subcloning were purchased from New England BioLabs (Ipswich, MA, USA). The Promega Wizard Miniprep kit (Madison, WI, USA) was used for plasmid DNA purification. DNA sequencing was performed by the University of Michigan Biomedical Resources Core Facility. Metal salts used for assays were purchased as high-purity solids from Alfa-Aesar (Ward Hill, MA, USA) and used without further purification.
Bacterial strains, plasmids, primers, and growth media. The bacterial strains, primers, and plasmids used in this study are described in Table  1 . E. coli TCM15 is a derivative of BW30270, E. coli K-12 MG1655 rph ϩ fnr ϩ , in which the gutQ and kdsD genes were disrupted via the phage Red recombinase system (6, 12) . All strains were grown in lysogeny broth (LB) medium (13) . TCM15 cultures were supplemented with A5P (15 M) and D-glucose-6-phosphate (G6P; 10 M). A5P is necessary to complement the API defect, and G6P induces the transporter necessary for the uptake of A5P (8) .
Cloning, expression, and purification of B. fragilis Q5LIW1. The YP_209877.1 gene, referred to here by the GenBank ID YP_209877.1, encoding Q5LIW1, was amplified from the genomic DNA of Bacteroides fragilis NCTC 9343 using the primers BF0137START and BF0137STOP (Table 1) , which were designed to incorporate NdeI and BamHI sites. PCR products were purified via extraction from a 1% (wt/vol) agarose gel using a Qiagen QIAquick gel extraction kit, inserted into vector pCR2.1-TOPO using the TA TOPO cloning kit, and subcloned, after digestion of the insert-containing vector with NdeI and BamHI, into similarly restricted expression vector pT7-7 (14) . The resulting plasmid, pT7-7-YP_209877.1, was transformed into E. coli TOP10 chemically competent cells. DNA sequencing of the resulting plasmid, pT7-7-YP_209877.1, confirmed that the YP_209877.1 gene sequence was identical to the sequence published in the NCBI entry. This plasmid was subsequently transformed into E. coli Rosetta 2 (DE3) pLysS chemically competent cells. A fresh transformant was grown in LB medium supplemented with 100 mg/liter ampicillin and 30 mg/liter chloramphenicol at 37°C while being shaken at 250 rpm until the optical density at 600 nm reached 0.6. The culture was cooled to 19°C, and expression of protein was induced with the addition of isopropyl-␤-D-1-thiogalactopyranoside to 0.42 mM. After 16 h of incubation at 19°C, cells were harvested by centrifugation (6,000 ϫ g, 10 min, 4°C). The pellet was suspended in 25 ml buffer B (40 mM Tris-HCl, pH 7.5), sonicated on ice (3 cycles of 20-s bursts, 2-min pauses between pulses), and clarified by centrifugation at 18,000 ϫ g for 30 min. Solid ammonium sulfate was slowly added, while the mixture was being stirred, to the clarified lysate to reach 50% saturation at 4°C, and stirring was continued for an additional 10 min. Precipitated proteins were removed by centrifugation at 15,000 ϫ g for 25 min, and solid ammonium sulfate was slowly added to the supernatant to reach 60% saturation (at 4°C) while the mixture was being stirred. The solution was stirred for an additional 10 min after the final addition of ammonium sulfate. Q5LIW1 was pelleted, along with some contaminating proteins, by centrifugation at 15,000 ϫ g for 25 min and resuspended in buffer A (40 mM Tris-HCl, pH 7.5, 1.4 M ammonium sulfate) prior to being passed through an 0.22-m Millipore polyvinylidene difluoride (PVDF) filter. The solubilized protein was loaded onto a phenyl-Superose column, which had been equilibrated with buffer A. Protein was eluted with an inverse linear gradient of 40 to 100% (vol/vol) buffer B in buffer A over 15 column volumes at 0.5 ml/min. Fractions containing Q5LIW1, as determined by SDS-PAGE, were pooled and concentrated using an Amicon ultracentrifugal filter (10,000-molecular-weight cutoff [MWCO]), and buffer was exchanged into 40 mM Tris-HCl, pH 7.5, and 25% (vol/vol) glycerol and stored at Ϫ80°C. Site-directed mutagenesis, expression, and purification of E. coli kdsD⌬2CBS. Plasmid template DNA (pT7-7-yrbH, approximately 0.5 pmol) was added to a PCR cocktail containing 1ϫ PfuTurbo buffer, 200 M (each) deoxynucleoside triphosphate (dNTP), 3 M EcKdsD⌬2CBS.F and EcKdsD⌬2CBS.R, and 2.5 U PfuTurbo DNA polymerase. The reaction mixture was incubated in an MJ Research PTC-200 thermal cycler with standard site-directed mutagenesis parameters. The reaction mixture was digested with DpnI for 1 h at 37°C and purified via extraction from an agarose gel. The resulting plasmid, pT7-7-EcKdsD⌬2CBS, was transformed into E. coli TOP10 chemically competent cells. DNA sequencing of the plasmid pT7-7-EcKdsD⌬2CBS confirmed that the kdsD gene had been truncated to include a stop codon between the SIS domain and first CBS domain (resulting in a gene encoding a 213-amino-acid protein). The plasmid was subsequently transformed into E. coli BL21(DE3) chemically competent cells. A fresh transformant was grown, and cells were harvested as described above. EcKdsD⌬2CBS was purified via a Hi-Load (16/10) Q-Sepharose fast-flow column, followed by ammonium sulfate precipitation as previously described (5) .
Molecular mass determination. The subunit mass of Q5LIW1 was determined via electrospray ionization mass spectrometry utilizing an LCT electrospray/time of flight spectrometer. The native molecular mass of Q5LIW1 was estimated by gel filtration chromatography on a HiPrep (26/60) Sephacryl S-100 column. Standards, run in triplicate, included bovine serum albumin (BSA) dimer (132.4 kDa), BSA monomer (66.2 kDa), chicken egg white ovalbumin monomer (44.3 kDa), and cytochrome c (12.4 kDa). A log(molecular mass)-versus-elution volume/void volume (V e /V o ) plot was fitted by linear regression, using Microsoft Excel. The molecular mass of Q5LIW1 was determined experimentally by measuring its elution volume and calculating the log(molecular mass) from the standard curve.
Metal content analysis. Enzyme samples were prepared for metal content analysis by 24 h of dialysis at 4°C against 2 liters of metal-free 40 mM Tris-HCl (pH 8.5) buffer and stored in metal-free glass vials. The divalent metal content, of each sample and of the buffer used in dialysis as a control, was determined using high-resolution inductively coupled plasma mass spectrometry on a Finnigan MAT Element instrument at the University of Michigan Department of Geology.
Substrate specificity. To determine the ability of recombinant Q5LIW1 to convert aldoses to ketoses, the enzyme was assayed with various aldoses, including A5P, G6P, D-glucose-1-phosphate, D-ribose-5-phosphate, D-arabinose, D-mannose-6-phosphate, D-glucosamine-6-phosphate, and D-ribose using the discontinuous cysteine-carbazole assay (5) . For each potential substrate, in triplicate, a 50-l solution of 100 nM enzyme, 100 mM 2-bis(2-hydroxyethyl)amino-2-(hydroxymethyl)-1,3-propanediol (Bis-Tris propane), pH 8.5, and 10 mM substrate was incubated for 10 min at 37°C before being quenched with an equal volume of 25 N H 2 SO 4 . A 90-l aliquot was transferred to a separate microplate containing a freshly prepared cysteine-carbazole assay mixture (10 l of a 0.12% ethanolic carbazole solution, 10 l of 1.5% aqueous cysteine-HCl, and 230 l of 25 N H 2 SO 4 ) and incubated at room temperature (ϳ21°C) for 3 h to develop color. Enzyme substrates were identified by comparing the color of the reaction to the color of a no-enzyme control.
Complementation of a kdsD/gutQ defect in E. coli. Electrocompetent cells were prepared, from the E. coli TCM15 variant that carries a kanamycin resistance cassette, by growing the cells in LB medium until early log phase (optical density at 600 nm, ϳ0.5). The cells were then harvested via centrifugation and washed three times in ice-cold 10% glycerol (8) . Empty pT7-7 vector, pT7-yrbH, pT7-7-EcKdsD⌬2CBS, pT7-7-c3406, and pT7-7-YP_209877.1 were separately transformed into electrocompetent E. coli TCM15 cells. Transformed cells were grown on LB agar plates supplemented with 100 mg/liter ampicillin, 50 mg/liter kanamycin, 15 M A5P, and 10 M G6P. Liquid LB medium supplemented with the same concentrations of antibiotics, A5P, and G6P was inoculated with single colonies, which were grown overnight at 37°C. Cells were washed twice, by centrifugation at 3,300 ϫ g and resuspension in liquid LB medium, to remove A5P and G6P in the overnight culture; streaked on LB/ agar plates with and without A5P/G6P; and incubated overnight at 37°C. Genes that complemented the API defect allowed the transformed cells to grow both with and without added A5P/G6P.
Determining the pH rate profile of Q5LIW1. The optimal pH for Q5LIW1 was determined by assaying the enzymatic activity of Q5LIW1, using the discontinuous cysteine-carbazole assay, in a series of buffer solutions of various pHs. Buffer solutions (200 mM buffer, 2 mM EDTA) were prepared in 0.25 pH increments from 5.0 to 9.5 at 37°C. 2-(N-Morpholino)ethanesulfonic acid (MES) buffer was used from pH 5.0 to 6.0, and Bis-Tris propane buffer was used from pH 6.25 to 9.5. Final reaction concentrations were 100 mM buffer, 1 mM EDTA, 10 mM A5P, and 400 nM enzyme. Reaction mixtures were incubated at 37°C for 3 min before being quenched with equal volumes of 25 N H 2 SO 4 . Quenched reactions were developed, as described above, and incubated at room temperature (ϳ21°C) for 3 h before the absorbance was measured at 540 nm. The enzymatic activity at each pH was determined in triplicate, and reaction rates were determined by fitting time points using linear regression.
Enzyme kinetics. Kinetic parameters for the isomerization of A5P to Ru5P or G6P to D-fructose-6-phosphate (F6P) catalyzed by Q5LIW1 and EcKdsD⌬2CBS were determined, in triplicate, using the discontinuous cysteine-carbazole assay with 100 nM Q5LIW1 or EcKdsD⌬2CBS, 100 mM Bis-Tris propane (pH 8.5), 1 mM EDTA, and substrate concentrations ranging from 0.156 mM to 20 mM A5P or 0.195 mM to 25 mM G6P. Individual assay mixtures, which were preheated at 37°C for 3 min before the addition of enzyme to initiate the reaction, and appropriate controls were allowed to react for 3 min at 37°C before being quenched with equal volumes of 25 N H 2 SO 4 . The quenched reaction mixtures were developed as described above. Control reactions, with Ru5P/F6P, showed that less than 10% of the substrate was converted to product under all conditions tested. Kinetic parameters were obtained by fitting the data to the Michaelis-Menten equation using nonlinear least-squares regression with GraphPad Prism 5 software.
Assay of A5P isomerase activity. Kinetic parameters for the isomerization of Ru5P to A5P were determined, in triplicate, using a modified coupled Aminoff assay utilizing the 3-deoxy-D-manno-octulosonate 8-phosphate synthase (Kdo8PS) from Arabidopsis thaliana (15, 16) . Reaction mixtures containing final concentrations of 10 mM phosphoenolpyruvate (PEP), 0.15 mg/ml Kdo8PS, 100 mM Bis-Tris propane (pH 8.5), and 1 mM EDTA and final concentrations of Ru5P ranging from 0 to 10 mM were heated separately from mixtures of Q5LIW1 or EcKdsD⌬2CBS (100 nM final concentration) to 37°C for 3 min. The reaction was then initiated by the addition of Q5LIW1 or EcKdsD⌬2CBS, and the reaction mixture was incubated for 2 min at 37°C. Reactions were quenched with an equal volume of 10% (wt/vol) trichloroacetic acid. To develop the color, 50 l of each reaction mixture was transferred to a separate glass tube, after which 100 l of a solution containing NaIO 4 (25 mM) and H 2 SO 4 (0.125 N) was added, followed by incubation for 10 min at room temperature (ϳ21°C). The addition of 200 l of a solution containing NaAsO 2 (2%, wt/vol) and HCl (0.5 N) neutralized the excess NaIO 4 . After the disappearance of the color, a solution containing 500 l of 0.36% thiobarbituric acid, pH 9.0, was added and the reaction mixture was incubated at 95°C for 10 min. These mixtures were transferred to a 96-well flat-bottom plate, and the absorbances were read at 549 nm. Data were fitted using the nonlinear least-squares regression function of GraphPad Prism 5 software.
D-Glucose-6-phosphate isomerase assays. To determine the kinetic parameters for the isomerization of F6P to G6P catalyzed by Q5LIW1, a coupled assay was used, in which the G6P produced by Q5LIW1 was oxidized to 6-phosphoglucono-␦-lactone by glucose-6-phosphate dehydrogenase and the cofactor NADP ϩ . The formation of NADPH was measured at 340 nm, which allowed for reaction progress to be monitored (17) . Individual reactions were performed in a quartz cuvette, in triplicate. The coupling enzyme (E. coli D-glucose-6-phosphate dehydrogenase, gene name zwf) was diluted into 2ϫ reaction buffer (200 mM Bis-Tris propane, pH 8.5, 2 mM EDTA) to a final coupling enzyme concentration of 1 M. NADP ϩ (0.16 mM final concentration) and F6P (0.01 to 3 mM final concentration) were subsequently added to the reaction mixture, which was allowed to incubate for 1 min at room temperature (ϳ21°C). The reaction was initiated by the addition of Q5LIW1 (final concentration, 100 nM), and the absorbance, at 340 nm, was monitored at 10-s intervals for 5 min, using a Hewlett-Packard 8453 diode array spectrophotometer. Initial reaction rates (nM/s) were determined by analysis of progress curves via linear regression. Kinetic parameters were obtained by fitting of the rate versus substrate concentration data, from assays performed in triplicate, to the Michaelis-Menten equation using nonlinear least-squares regression in GraphPad Prism 5.
Generation of CMP-Kdo. CMP-Kdo was generated using E. coli CMP-Kdo synthetase (KdsB) (18) . In a typical reaction, CTP (0.55 mM) and Kdo (1.1 mM), were added to 4ϫ reaction buffer (400 mM Bis-Tris propane, pH 8.5, 5 mM MgCl 2 ), and the reaction was initiated by addition of KdsB to a final concentration of 13.2 g/ml. The reaction was allowed to incubate for 10 min at room temperature before being quenched with EDTA (45 mM final concentration).
The Eikonogen assay (19, 20) , which allows for the direct correlation of the concentration of CMP-Kdo with the amount of inorganic pyrophosphate produced, was used to determine the concentration of inorganic pyrophosphate produced. In this assay, the CMP-Kdo solution (50 l) was treated with 2.5% ammonium molybdate (50 l), 0.5 M ␤-mercaptoethanol (50 l,) and Eikonogen reagent (20 l, 0.125 g sodium sulfite, 7.325 g sodium metabisulfite, and 0.125 g 1-amino-2-naphthol-4-sulfonic acid in 50 ml hot deionized water). The mixture was incubated at room temperature (ϳ21°C) for 30 min, and the absorbance was read at 540 nm. A malachite green assay, as previously described, was used to correct for inorganic phosphate concentrations (20) . Absorbances were compared to a standard curve prepared using a serial dilution of a standard aqueous solution of Na 2 P 2 O 7 . Data were analyzed by linear regression in Microsoft Excel.
Inhibition kinetics with CMP-Kdo. To test if recombinant Q5LIW1 was inhibited by CMP-Kdo, a coupled assay in which the Ru5P produced by Q5LIW1-catalyzed isomerization of A5P was reduced to ribitol using an excess of NADPH and the enzyme Bcs1 (CDP-ribitol synthase) was performed. Reaction mixtures containing A5P (0.25 mM or 0.50 mM), Bis-Tris propane buffer (100 mM; pH 8.5), EDTA (1 mM), NADPH (0.16 mM), and Bcs1 (96 g/ml) (21) were incubated separately from mixtures containing Q5LIW1 (100 nM) and CMP-Kdo (final assay concentrations ranging from 0 to 68.51 M) for 3 min at 37°C. The enzyme-inhibitor mixture was added to the reaction mixture, mixed for 20 s, and incubated at 37°C for 10 min while the absorbance at 340 nm was monitored every 24 s using a SpectraMax M5 microplate reader (Molecular Devices). Absorbance values were plotted versus time in Microsoft Excel and fitted using linear regression. The slopes were converted to reaction rates in nM/s. Rates were plotted as a function of inhibitor concentration in GraphPad Prism 5 and fitted using the nonlinear least-squares technique to a model of competitive inhibition based upon the Michaelis-Menten equation. Rates were converted to percent response of maximum, and the log(response)/(1 Ϫ response) was plotted versus log[CMP-Kdo] in Microsoft Excel to generate a Hill plot (see Fig. 6B ).
Equilibrium constant (K eq ) determination. Solutions containing 100 mM Bis-Tris propane buffer, pH 8.5, 1 mM EDTA, 10% D 2 O, 500 nM Q5LIW1 or EcKdsD⌬2CBS, and a 5 mM concentration of F6P, G6P, A5P, or Ru5P were incubated at room temperature (ϳ21°C) for 72 h, sufficient to reach equilibrium. These solutions were analyzed by 31 P nuclear magnetic resonance (NMR) using a Varian 400 multinuclear NMR spectrometer. A solution of 0.05 N phosphoric acid standard was sealed within a capillary tube and set to a value of 0 ppm. Spectra were acquired using 64 scans with a 10-s relaxation delay between scans. Preliminary studies with longer relaxation times did not show a change in peak integrations, which supports the assumption that the chosen delay time was greater than three times the T1 relaxation parameter for G6P, F6P, A5P, and Ru5P.
Effect of divalent metal ions on the API activity of Q5LIW1. To determine the effect of divalent metal ions on the API activity of Q5LIW1, samples of Q5LIW1 were diluted in buffer containing 108.2 mM Bis-Tris propane, pH 8.5, and 10.82 M EDTA or divalent metal salt and incubated on ice for 30 min. The API activity was assayed using the Aminoff assay (15) . Final concentrations in each reaction mixture were 100 nM Q5LIW1, 100 mM Bis-Tris propane (pH 8.5), 0.15 mg/ml KdsA, 10 mM PEP, and 5 mM Ru5P. Reaction mixtures were incubated for 3 min at 37°C before being quenched with an equal volume of 10% (wt/vol) trichloroacetic acid, and the color was developed as described above in the A5P isomerization assay. 
RESULTS
Expression and characterization of Q5LIW1 and EcKdsD⌬2CBS. (i)
Q5LIW1 is one of a small group of single SIS-domain proteins. A BLASTP search using YP_209877.1 as the query sequence revealed putative SIS-domain proteins in Gram-negative bacteria of the genera Bacteroides, Parabacteroides, Dysgonomonas, and Porphyromonas. In each case, the YP_209877.1 homolog was the only putative API discovered within the genome; no CBS domain-containing APIs were identified. The B. fragilis NCTC 9343 genome contains orthologs of all the other enzymes in the E. coli K-12 Kdo biosynthesis pathway, including KdsA (locus YP_210629; E value, 7e Ϫ75 ), KdsB (locus YP_211897; E value, 2e Ϫ38 ), KdsC (locus YP_212734; E value, 4e Ϫ31 ), and WaaA (locus YP_213607; E value, 1e Ϫ42 ). Taken together, these observations suggest that Q5LIW1 and its homologs constitute a unique group of SIS-domain APIs responsible for supporting Kdo biosynthesis in these Gram-negative organisms.
(ii) Recombinant Q5LIW1 is a tetramer. Locus YP_209877.1 was cloned by PCR from B. fragilis NCTC 9343 genomic DNA obtained from the ATCC and inserted into the plasmid pT7-7 (9). Overexpression in E. coli Rosetta (DE3) pLysS cells produced sufficient quantities of protein that were purified using ammonium sulfate fractionation and chromatography on a phenyl-Sepharose column. The purified protein migrated at approximately 21 kDa on an SDS-PAGE gel; its subunit molecular mass was determined to be 21,809.99 Da (calculated, 21,810.2) by electrospray mass spectroscopy. The quaternary structure of the protein was probed using gel filtration chromatography (Fig. 1) . Native Q5LIW1 eluted with an apparent molecular mass of 85,871.3 Da, approximately 3.94 times the subunit mass. This result is almost identical to the results obtained with the APIs of E. coli, which behave as tetramers in solution (5, 6, 8) . Metal content analysis showed that the purified protein, as isolated, did not contain any metals. Inhibition tests with added divalent metals showed that only Cu 2ϩ had an inhibitory effect on the isomerization of A5P to Ru5P, amounting to a roughly 4-fold decrease in activity (Fig. 2) .
Based on a sequence comparison, E. coli kdsD, in the expression vector pT7-7, was truncated to produce a single SIS domain by site-directed mutagenesis to insert a stop codon after 213 amino acids (Asp214*).The resulting pT7-7-EcKdsD⌬2CBS was moved to E. coli BL21(DE3), expressed, and purified.
Enzymatic properties of Q5LIW1 and EcKdsD⌬2CBS. (i) Recombinant Q5LIW1 is an API. The substrate specificity of Q5LIW1 was investigated by testing its ability to catalyze the isomerization of a series of aldose phosphates. These experiments were performed at pH 6.5 based on the pH optimum observed for the c3406 protein (8) . Q5LIW1 converted two of the substrates, A5P and G6P, to the corresponding ketoses. The pH-rate profile was investigated using A5P as the substrate (Fig. 3) . It was determined that Q5LIW1 has a very broad pH profile with an optimum ranging from 7.75 to 9.0.
(ii) Enzyme kinetics. Kinetic parameters were determined for the interconversion of A5P and Ru5P at pH 8.5. A comparison of the kinetic constants obtained for Q5LIW1 and EcKdsD⌬2CBS with those previously obtained for the APIs of E. coli is shown in Table 2 .
Kinetic constants for the conversion of F6P to G6P (phosphoglucose isomerase catalysis) were also determined for Q5LIW1: (6) is a derivative of BW30270 in which both kdsD and gutQ have been deleted. To support the growth of TCM15, minimal medium must be supplemented with A5P (to support LPS biosynthesis) and G6P (to induce a transport system, uhp, that internalizes A5P) (22) . This A5P/G6P auxotrophy can be circumvented by expression of an active API from a plasmid within the cell. As a test of the ability of Q5LIW1 to complement an API deficiency within bacterial cells, E. coli TCM15 was transformed with the plasmid pT7-7-YP_209877.1, pT7-7-c3406 (positive control), or pT7-7 (vector control). In this system, the plasmid inserts are expressed from a leaky T7 promoter. Equal numbers of cells were plated on morpholinepropanesulfonic acid (MOPS) minimal medium containing glycerol and either containing or lacking A5P/G6P (Fig. 4) . Q5LIW1 is able to complement the lack of A5P/G6P in the medium and is therefore an active API in E. coli TCM15.
(ii) EcKdsD⌬2CBS complements the API defect in E. coli strain TCM15. As a test of the ability of EcKdsD⌬2CBS to complement an API deficiency within bacterial cells, E. coli TCM15 was transformed with pT7-7 (vector control), pT7-yrbH (positive control, wild-type kdsD), or pT7-7-EcKdsD⌬2CBS. Equal numbers of cells were plated on LB medium either containing or lacking A5P/G6P (Fig. 5) . EcKdsD⌬2CBS is able to complement the lack of A5P/G6P in the medium and therefore displays API activity in E. coli TCM15.
CMP-Kdo inhibits the API activity of Q5LIW1. CMP-Kdo, the final product of the Kdo biosynthetic pathway, is used by the enzyme Kdo transferase (WaaA) to transfer Kdo to lipid IV A . We tested the hypothesis that CMP-Kdo is a feedback inhibitor of Q5LIW1. CMP-Kdo, which is not commercially available and must be made in the lab, autohydrolyzes in aqueous solution (25°C, pH 7.5) with a half-life of approximately 34 min (23) . This limitation was circumvented by performing API assays using CMP-Kdo that was generated in situ using CTP, Kdo, and CMP- Kdo synthetase (KdsB) from E. coli. This process generated high micromolar concentrations of CMP-Kdo, as determined using the Eikonogen assay (20) . The addition of CMP-Kdo-containing mixtures to Q5LIW1 enzymatic assays caused a substantial decrease in the activity of Q5LIW1 (K i of 1.91 Ϯ 0.48 M) (Fig. 6A) . Addition of mixtures that lacked KdsB and were, therefore, devoid of CMPKdo did not inhibit the API activity of Q5LIW1. A Hill plot of these data shows a 1:1 binding ratio of Q5LIW1 to CMP-Kdo, suggesting that CMP-Kdo binds noncooperatively; however, we cannot rule out the possibility of negatively cooperative binding (Fig. 6B) .
DISCUSSION
The data presented in this report strongly support the hypothesis that Q5LIW1 is a physiologically relevant API that is responsible for the generation of A5P necessary to support LPS biosynthesis in B. fragilis. A BLASTP search of the genomes of other Gram-negative obligate anaerobes, using Q5LIW1 as the query sequence, yielded several hits of species which contain putative SIS-domain proteins but do not contain a putative API with CBS domains. This suggests that single SIS-domain APIs may be utilized as the sole API in several Gram-negative obligate anaerobes. The slow growth of these obligate anaerobes should diminish the rate of Kdo biosynthesis required to sustain viability, compared with facultative anaerobes like E. coli, and thus diminish the rate at which A5P must be produced. Therefore, it is reasonable to conclude that an API such as Q5LIW1, which has a somewhat lower k cat /K m than that of E. coli KdsD, would be able to support cell viability.
Experiments with E. coli TCM15 showed that Q5LIW1 could complement an API-deficient strain. This demonstrates that Q5LIW1 can serve as the sole source of A5P to support LPS biosynthesis in E. coli TCM15. The substrate specificity of Q5LIW1 was probed utilizing a series of aldose phosphates. Unlike previously characterized APIs, which are specific to the isomerization of Ru5P and A5P, Q5LIW1 was able to catalyze the isomerization of A5P to Ru5P as well as that of G6P to F6P. However, the phosphoglucose isomerase activity of Q5LIW1 is very weak and likely not physiologically relevant. The pH optimum for the isomerization of A5P to Ru5P by Q5LIW1 was found to include a broad range from 7.75 to 9.0. This pH optimum is similar to that of the two-domain APIs of E. coli (KdsD, GutQ, and KpsF) (5, 6, 7). Conversely, c3406, a SIS-domain API, has a sharp pH rate profile with an optimum pH of 6.6 (8) . The kinetic parameters, for the isomerization of A5P as well as G6P to the corresponding ketoses, were determined. The kinetic profile of Q5LIW1 is very similar to that of c3406 (Table 2) for the isomerization of A5P, further suggesting that SIS-domain APIs may be able to serve as the sole A5P source to support LPS biosynthesis. These results led to the hypothesis that a truncation of the two CBS domains of E. coli KdsD would result in a protein that would maintain API activity and potentially complement E. coli TCM15. EcKdsD⌬2CBS (a 213-amino-acid protein including only the SIS domain of E. coli KdsD) was cloned, overexpressed, and purified. Complementation studies Agar plate containing MOPS medium supplemented with 0.1 mg/ml ampicillin and 0.05 mg/ml kanamycin. In both panels, the wedges were streaked with E. coli TCM15 harboring pT7-7 (vector control, wedge 1), E. coli TCM15 harboring pT7-7-c3406 (c3406 control, wedge 2), and E. coli TCM15 harboring pT7-7-Q5LIW1 (Q5LIW1, wedge 3). In both panels, the wedges were streaked with: E. coli TCM15 harboring pT7-7 (vector control, wedge 1), E. coli TCM15 harboring pT7-7-yrbH (KdsD wildtype control, wedge 2), and E. coli TCM15 harboring pT7-7-KdsD⌬2CBS (KdsD truncated to contain only the SIS domain, wedge 3).
with EcKdsD⌬2CBS showed that the truncated gene could complement the API defect in E. coli TCM15. The kinetic parameters of the truncated enzyme were also determined; EcKdsD⌬2CBS demonstrated a 5-fold decrease in catalytic efficiency in the A5P-to-Ru5P direction compared to wild-type KdsD (Table 2 ). In the Ru5P-to-A5P direction, the catalytic efficiency of EcKdsD⌬2CBS resembles the single-domain APIs of Q5LIW1 and c3406 more than it does the CBS domain-containing APIs of E. coli. The finding that single-domain APIs may serve as the sole API in several bacterial species led us to question how this unique group of APIs might be regulated. Because APIs catalyze the first step in Kdo biosynthesis, it is logical that the final product of the Kdo biosynthetic pathway, CMP-Kdo, may serve as a feedback inhibitor to regulate the pathway. In this paper, we demonstrated that CMP-Kdo inhibits Q5LIW1 with a K i of 1.91 M. Our inhibition experiments confirm the biological significance of CMPKdo within the active site of Q5LIW1 in the PDB (PDB ID 3ETN). These results give insight into a potential regulation mechanism of single-domain APIs. However, it is unclear if this regulation mechanism also applies in vivo. Based on the fact that Q5LIW1 may be regulated by CMP-Kdo feedback inhibition, we speculate that other single SIS-domain APIs, such as c3406, can also be regulated by CMP-Kdo. We further speculate that two-domain (CBS domain-containing) APIs may be regulated by CMP-Kdo, but it is unclear what role the CBS domain would play in this process. The discovery of this potential regulation mechanism of the single-domain API, Q5LIW1, has provided a first glimpse of insight into understanding the regulation of APIs in the biosynthesis of Kdo and could serve as a model of structure-function studies of APIs.
